Gavia Research Personal Finance and learning to invest
Welcome to Gavia Research, a community where you can learn to invest and take care of your personal finances. Gavia Research is a blog / newsletter focused on personal finance and investing. We write articles on how you can save more money and invest better. The goal is to make you able to live a more fulfilling financial life.
Some of the topics we’ve written about so far are saving money on taxes, investing like Peter Lynch in 2021 and investing in bargain-priced Chinese stocks.
We aim to provide value primarily for young professionals. Of course, readers of all ages are welcome. The topics we write about are such that might be most useful for young people building out their careers and planning out their financial futures.
Below are wise words from two of our favourite spiritual mentors. These gentlemen are Peter Lynch and Warren Buffett. Both are famous for their immaculate investing taste. Besides investing, they both have an ocean of other wisdom to bring to the table. For one who wants to learn to invest it would be wise to read what these wise men have said.
“The trick is not to learn to trust your gut feelings, but rather to discipline yourself to ignore them. Stand by your stocks as long as the fundamental story of the company hasn’t changed.
– Peter Lynch
“Calling someone who trades actively in the market an investor is like calling someone who repeatedly engages in one-night stands a romantic.”
– Warren Buffett
“The stock market is designed to transfer money from the active to the patient.”
– Warren Buffett
In the modern day, audiobooks are all the rage. Here below you can find some of our favourites. These are from authors we hold in great esteem and have learned the majority of our investing principles from.
Gavia Research produces a monthly newsletter that you can become a subscriber to. In the newsletter we provide summaries of our latest stories. We also provide bonus content that can’t be found on the website.
achievable analysis best stock china china stock chinese stock chinese stocks company earnings growth financial goals finv stock fundamental analysis garp goal growth growth at reasonable price guide insider invest investing measurable momo stock money obci obci stock ocean biochem personal finance peter lynch realistic revenue growth saving small cap smart goals specific stock analysis stock market stock market investing strategy ticker symbol tips trackable tutorial value investing value stock volatility
- Diverse Investment In Global Stocks and Real Estate – Guide To Diversified Investing
Diversifying your investments, diverse investment, is what most advisors tell you to do. Read our guide on stocks, real estate and other assets to find out how. What asset classes can you invest in as a private person? Stocks of…Read More “Diverse Investment In Global Stocks and Real Estate – Guide To Diversified Investing” »
- Dividend Stocks – Pros And Cons Vs Investing In A Stock Not Paying Dividends
Dividend stocks according to some experts provide a cushion against a market downturn. Why would we invest in companies paying no dividend? Read the article to know why! Dividend definition A dividend is a payment made by a company to…Read More “Dividend Stocks – Pros And Cons Vs Investing In A Stock Not Paying Dividends” »
- Invest With No Money – A How To Guide To Building Your Investment Portfolio From Nothing
Invest with no money – how can you invest as a teenager or a person without a job? In this article we discuss how to start your investment journey from zero to hero. What Is An Investment And Which Investment… - FSI Stock – Flexible Solutions International The Under The Radar Micro Cap For GARP Investing
FSI stock is a micro cap going under the radar of most institutions. We believe the rock solid balance sheet, growth at reasonable price and a solid management team make it an investment yielding at least 13% a year. What… - Organon Stock: Merck Womens’ Health Spinoff IPO Selloff Creates Value Investing Opportunity
Organon stock started trading on 3 June 2021. The stock was spun off from Merck & Co., a major pharmaceuticals company. Since it’s IPO, OGN has lost 15% in price. Does the selloff create a value investing opportunity? Read our…
